Reversing cognitive-decline in older adults in an open-label clinical trial: novel mechanisms and the role of GlyNAC

Lignende værker

• Supplementing Glycine and N-acetylcysteine (GlyNAC) in Aging HIV Patients Improves Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Endothelial Dysfunction, Insulin Resistance, Genotoxicity, Strength, and Cognition: Results of an Open-Label Clinical Trial
  af: Kumar, Premranjan, et al.
  Udgivet: (2020)
• Glycine and N‐acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial
  af: Kumar, Premranjan, et al.
  Udgivet: (2021)
• Reversing Mitochondrial, Metabolic and Molecular Defects in the Brain Improves Cognition in Aged Mice
  af: Sekhar, Rajagopal, et al.
  Udgivet: (2020)
• Reversing Cognitive Decline in Aging: Reversible Mechanistic Defects and a Novel Nutritional Intervention
  af: Sekhar, Rajagopal, et al.
  Udgivet: (2020)
• GLUTATHIONE, MITOCHONDRIAL DEFECTS, AND A UNIQUE METABOLIC CYCLE IN OLDER HUMANS: IMPLICATIONS FOR SARCOPENIA
  af: Sekhar, Rajagopal V, et al.
  Udgivet: (2019)